TPTX - Turning Point Therapeutics, Inc

Healthcare - Sector

TPTX is currently covered by 11 analysts with average potential upside of $24.05 (41.94%) backed by 43 price targets and 74 ratings. Analyst's average stock valuation to be materialised ratio is 73.02% with an average time for price targets to be met of 95.27 days.

Most recent stock forecast was given by ANDREW BERENS from LEERINK on 13-Jun-2022.

Highest price target for TPTX is 132, Lowest price target is 29, average price target is 80.5.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

76

$-0.01 (-0.01%)

127

5 months 23 days ago

5/5 (100%)

$9.35 (17.11%)

34

Hold

72

$-4.01 (-5.28%)

80

5 months 23 days ago

1/2 (50%)

$7.36 (11.96%)

256

Buy

76

$-0.01 (-0.01%)

6 months ago

6/6 (100%)

$24.27 (46.61%)

112

76

$-0.01 (-0.01%)

105

6 months 3 days ago

5/11 (45.45%)

$47.88 (93.53%)

53

Buy

76

$-0.01 (-0.01%)

63

6 months 3 days ago

2/2 (100%)

$10.74 (24.31%)

88

Show more analysts

This chart will make you best informed on how analysts see your stock and which of them does well in less than two minutes.

28 days free trial

We do our best to collect, sort, and check every available news item on your stocks so that you can focus on what is important

For each analyst know for every call if it has been before or after the stock price moved

Understand how each analyst reacts to stock price movement

Get Started or Login